Safety and Immunogenicity of a Subvirion Inactivated Influenza A/H5N1 Vaccine with or without Aluminum Hydroxide Among Healthy Elderly Adults

Antzeko izenburuak

• Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I—II Randomized Clinical Trial
  nork: Keitel, Wendy A., et al.
  Argitaratua: (2008)
• Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes
  nork: Patel, Shital M., et al.
  Argitaratua: (2012)
• Safety and Immunogenicity of Inactivated, Vero Cell Culture-Derived Whole Virus Influenza A/H5N1 Vaccine Given Alone or with Aluminum Hydroxide Adjuvant in Healthy Adults
  nork: Keitel, Wendy A., et al.
  Argitaratua: (2009)
• Immunogenicity, Safety and Consistency Of New Trivalent Inactivated Influenza Vaccine
  nork: Talbot, H. Keipp, et al.
  Argitaratua: (2008)
• Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine
  nork: Winokur, Patricia L., et al.
  Argitaratua: (2015)